Since antirheumatic drugs might alter the immune response in benign lymphadenopathies [33], we investigated if patients treated with steroids and/or methotrexate had higher amounts of IDO1+ or PD-L2+ cells, since these patients might represent a group with high inflammatory activity in their AD. Here, IDO1 is linked to Alzheimer disease.